A-Cell Case Study: QbD Principles in Cell Therapy CMC

Published on Alliance for Regenerative Medicine

The Alliance for Regenerative Medicine’s A-Cell initiative showcases how Quality by Design (QbD) can be systematically integrated into cell-based therapy CMC programs. By applying structured risk assessment and data-driven frameworks, the project highlights practical ways to streamline manufacturing, enhance consistency, and accelerate clinical translation.

👉 Read the full article: A-Cell Case Study

Disclaimer

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full detail, refer to the original article via the provided link. SSCTR does not provide medical advice, and the views expressed are for educational purposes only.